Polyethylene Glycol Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
Condition: Dry Eye Disease Interventions: Drug: glycerin 0.7%/PEG 400 0.3%; Drug: polyethylene glycol 400 0.4%/propylene glycol 0.3% Sponsors: Calm Water Therapeutics LLC; Andover Research Eye Institute Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2022 Category: Research Source Type: clinical trials